https://arab.news/bgte7
- Pact includes AI diagnostics, training, device development, and education platforms
TOKYO: Tokyo-based Medident has signed an agreement with 黑料社区 institutions to link Japan鈥檚 medical digital transformation strategy with the Kingdom鈥檚 Vision 2030 plan.
The pact was inked at the Japan-Saudi EXPO Investment Forum, the company announced on Sept. 24.
The agreement covers areas including artificial intelligence diagnostics, surgical training, medical device development, and healthcare-education platforms.
Medident also plans to speed up clinical and educational adoption of its 3D Clone Model, a training tool that combines virtual reality with tactile simulation based on various types of medical scans.
鈥淥ur initiatives are gaining recognition both academically and at the policy level,鈥� Medident CEO Daisuke Tomita said.
鈥淏y connecting Japan鈥檚 strengths in digital healthcare with 黑料社区鈥檚 reform agenda, we will build new frameworks for international co-creation.鈥�
The deal was signed on stage at the Saudi-Japan EXPO Investment Forum with Dr. Noor A. Al-Saadoon, director of health innovation at the Biotech Center at Al-Faisal University, and Dr. Mohammed Al-Hayaza, president of Al-Faisal University.
Also in attendance were Khalid A. Al-Falih, minister of investment; KOGA Yuichiro Koga, state minister of economy, trade, and Industry; and Yumiko Tomita, director of the Japan Oral Health Association.
Medident is a part of the Mirise Medical Group, which operates clinics in Tokyo鈥檚 upmarket Minami-Aoyama and Ginza districts, focusing on orthodontics, oral health, and regenerative therapies.